Treasurer of the State of North Carolina’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,412
Closed -$357K 1051
2022
Q1
$357K Buy
4,412
+70
+2% +$10.4K ﹤0.01% 1015
2021
Q4
$880K Buy
4,342
+81
+2% +$17.6K ﹤0.01% 979
2021
Q3
$1.15M Buy
4,261
+144
+3% +$34.6K 0.01% 960
2021
Q2
$1.06M Sell
4,117
-120
-3% -$33.2K 0.01% 977
2021
Q1
$1.27M Sell
4,237
-11
-0.3% -$3.42K 0.01% 913
2020
Q4
$1.08M Buy
4,248
+11
+0.3% +$2.84K 0.01% 924
2020
Q3
$1.05M Sell
4,237
-4
-0.1% -$1.26K 0.01% 878
2020
Q2
$1.47M Sell
4,241
-379
-8% -$118K 0.01% 785
2020
Q1
$1.24M Buy
4,620
+1,920
+71% +$594K 0.01% 756
2019
Q4
$874K Buy
2,700
+23
+0.9% +$6.67K 0.01% 854
2019
Q3
$731K Sell
2,677
-6,243
-70% -$2.29M 0.01% 885
2019
Q2
$4.76M Buy
8,920
+1,273
+17% +$638K 0.03% 488
2019
Q1
$3.85M Sell
7,647
-20
-0.3% -$11.9K 0.02% 538
2018
Q4
$3.78M Buy
7,667
+93
+1% +$56.1K 0.03% 504
2018
Q3
$6.92M Buy
7,574
+5,229
+223% +$4.46M 0.04% 355
2018
Q2
$1.72M Buy
+2,345
New +$2.7M 0.02% 655

Other funds holding NKTR

Treasurer of the State of North Carolina's NKTR Position: Q2 2022 in Review

Treasurer of the State of North Carolina sold out of Nektar Therapeutics (NKTR) in Q2 2022, closing a stake of 4,412 shares — an estimated $357K sold.

Treasurer of the State of North Carolina first reported a position in NKTR in Q2 2018 and held it in 16 quarters. The position peaked at $6.92M in Q3 2018. 228 funds tracked by Wall St. Rank hold NKTR as of Q2 2022.

  • Treasurer of the State of North Carolina reported no remaining Nektar Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Treasurer of the State of North Carolina sold 4,412 Nektar Therapeutics shares in Q2 2022, an estimated $357K.
  • Treasurer of the State of North Carolina first reported a position in Nektar Therapeutics in Q2 2018 and held it in 16 quarters.
  • Treasurer of the State of North Carolina's Nektar Therapeutics position peaked at $6.92M in Q3 2018.
  • 228 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2022.

Based on Treasurer of the State of North Carolina's 13F filing for Q2 2022, filed 2 Aug 2022.